Science & Enterprise subscription

Follow us on Twitter

  • Genny Cream for me, if I were there https://t.co/BQcWbr7yLh
    about 1 hour ago
  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 7 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 7 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 10 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago

Please share Science & Enterprise

Biotechs Partner on Gene-Edited Cancer Cell Therapies

Natural killer cell

Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer. . . . → Read More: Biotechs Partner on Gene-Edited Cancer Cell Therapies

Cell Therapy Mfring Company Raises $82M in Venture Funds

T-cells and cancer cells

A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round. . . . → Read More: Cell Therapy Mfring Company Raises $82M in Venture Funds

AI Drug Discovery Company Acquired in $270M Deal

Four fist bump

A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms. . . . → Read More: AI Drug Discovery Company Acquired in $270M Deal

Microsoft, Biotech Partner on Metastatic Cancer

Lung cancer illustration

A biotechnology start-up is collaborating with Microsoft Corp. on computational tools to find and predict factors that cause cancers to spread. . . . → Read More: Microsoft, Biotech Partner on Metastatic Cancer

Clinical Trial Tests In-Tumor Breast Cancer Therapy

Breast cancer self exam

A clinical trial is set to begin that tests a treatment for early-stage breast cancer delivered directly into the tumor before surgery is scheduled. . . . → Read More: Clinical Trial Tests In-Tumor Breast Cancer Therapy

Precision Cancer Immunotherapy Biotech Underway

T-cells and cancer cells

A new company is beginning work on a safer form of cancer immunotherapy that avoids toxic off-target effects, and raising $55 million in venture funds. . . . → Read More: Precision Cancer Immunotherapy Biotech Underway

Engineered Macrophage Cells Tested in Cancer Trial

Macrophage

A clinical trial is underway testing immune system cells called macrophages, with added cancer-killing proteins, as a treatment for solid tumor cancers. . . . → Read More: Engineered Macrophage Cells Tested in Cancer Trial

Vaccine Spin-Off Raises $168 Million in New Funds

Syringes

A developer of vaccines, including a leading Covid-19 vaccine, and cancer immunotherapies, is raising $168 million in its second venture round. . . . → Read More: Vaccine Spin-Off Raises $168 Million in New Funds

Multiple Solid-Tumor Immunotherapy Trial Underway

Cancer on clipboard

A clinical trial is underway testing an immunotherapy for several types of stubborn solid tumor cancer, based on research in university labs. . . . → Read More: Multiple Solid-Tumor Immunotherapy Trial Underway

Micro Robotic Neuro Therapy Company Underway

Brain cell networks

A company designing microscale robotic devices to deliver therapies to the central nervous system began work in public on treatments for brain disorders. . . . → Read More: Micro Robotic Neuro Therapy Company Underway